Palace approved COVID-19 jabs to minors ages 12-17

MANILA, Philippines – The Palace has approved the recommendation of the Department of Health (DOH) for the inoculation of Minors ages 12-17 beginning in mid-October.

During the Palace briefing, the DOH said that the immunization will be done “by phase” to those minors ages 15-17. This will be followed by minors ages 12-14.

“Kinakailangan po talaga ng parental consent. Hindi pupuwedeng sila-sila na lamang ang pagdedesisyon,” Sec. Francisco Duque III said during the Palace briefing.

“Ito po ay ilulunsad sa ating mga ospital muna para nang sa ganoon kung magkaroon man ng mga adverse event following immunization ay at least nasa loob na po ng ospital at mabilis na matugunan,” he added.

So far, the Philippine Food and Drug (FDA) have approved Pfizer-BioNTech and Moderna for children. Sinovac on the other hand has yet to be approved by the FDA.

Pfizer has given the emergency use authorization (EUA) last May 2021 for safe use aged 12 years old and above while Moderna has recently amended the EUA last month.

Carlito Galzez Jr., National Task Force (NTF) Against COVID-19 chief implementer said the pilot vaccination for minors will be administered in Philippine Children’s Medical Center, National Children’s Hospital, Philippine Heart Center, Pasig City Children’s Hospital, Fe del Mundo Medical Center, and
Philippine General Hospital.

Is Covid-19 jabs safe for the minors?

According to the United States Food and Drug Administration (US FDA), Pfizer vaccines have been tested on minors ages 12-17 and the result was “outweigh the known and potential risks.”

In the study shown given by the FDA, the common adverse effect in the trial was discomfort at the injection site, fatigue, headache, chills, muscular pain, fever, and joint pain.

The Vaccinators should be aware of “very rare incidence of myocarditis” with mRNA vaccines such as Pfizer and Moderna.

“Very few, very rarely, one in for every million siguro— a few for every million na binakunahan at mas nakikita sa mga younger males. Ito po ang kailangan lamang bantayan. But definitely with the Delta variant affecting a lot of children, nakita po ng ating mga experts that the benefit of using the vaccine outweighs the risk,” Philippine FDA Director-General Eric Domingo said.

Your Comment

Do you have any comments/suggestions about this article? Please feel free to drop one below.

0 comments… add one

Leave a Reply

Your email address will not be published.